Since Leqembi was approved in the U.S. in the summer of 2023, controversy has roiled among clinicians over whether the Alzheimer’s anti-amyloid drug’s risks…
This article is part of the Diversity & Dementia series, produced by Being Patient with support provided by Eisai. Black Americans have nearly double…
You receive a text message from an unknown number: “I wrote this memo just for you and I really need you to take a…
This past three months in the Alzheimer’s drug development space have seen a new FDA approval for a symptomatic treatment, a couple failed phase…
Bob Toia, 77, had a career in drug research, developing clinical trials for new drug entities at Proctor and Gamble. During those years, he…
At the 2024 Clinical Trials on Alzheimer’s Disease (CTAD) conference in Madrid, Spain, scientists and drug development companies gathered to report on recent successes…
Would you want to know if you were on the road to Alzheimer’s 20 years before you have any memory loss? My feeling is…
For years, a commonly prescribed treatment for managing the symptoms of Alzheimer’s disease has been a type of drug called a cholinesterase inhibitor (ChEI)….
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. When you’re concerned about…
On October 23nd, the UK’s drug regulation agency — UK Medicines and Healthcare products Regulatory Agency — approved Eli Lilly’s anti-amyloid drug Kisunla for…
In just a single year of studying a rare genetic mutation in a single family in the Arctic reaches of remote northern Sweden, a…
Did you know 1/5 people who see a doctor with cognitive concerns are misdiagnosed? Dementia, in all its many forms — including Alzheimer’s, Parkinson’s,…
As Halloween approaches, families look forward to celebrations, costumes, and candy. However, for individuals living with dementia, the holiday’s sudden noises, flashing lights, and…
There was disagreement on social media recently after a story was published about an aged care provider creating “fake-away” burgers that mimicked those from…
Over 80 percent of people living with Alzheimer’s disease are unable to recognize their own cognitive decline, according to Cleveland Clinic. Anosognosia is the…